Skip to content
Open access

Hepatitis B Surface Antigen and Hepatitis C Antibody Seroprevalence Among Male Blood Donors in Lahore, Pakistan: A Cross-Sectional Study at Four Blood Banks

Oct 2026 · Electronic Journal of Medical Research · 0 citations · 32 references

TL;DR

Seroprevalence among male blood donors in Lahore, Pakistan represents screening-marker seroprevalence rather than confirmed active infection and should be interpreted within the limitations of rapid testing and the sampled male donor population.

Abstract

Hepatitis B virus (HBV) and hepatitis C virus (HCV) pose important challenges to blood safety, highlighting the need for continued surveillance among blood donors. This cross-sectional study assessed the seroprevalence of hepatitis B surface antigen (HBsAg) and anti-HCV antibodies among male blood donors at four blood banks in Lahore, Pakistan, and examined their associations with age and ABO/Rh blood group. A total of 600 donors were included, with 150 recruited from each of General Hospital Lahore, Services Hospital Lahore, Noor Thalassaemia Centre, and Zaib Ali Foundation. Serum samples were screened using immunochromatographic rapid tests. Seroprevalence estimates were calculated with 95% Wilson confidence intervals (CIs). Associations with blood group were assessed using chi-square tests, and age distributions were compared using the Mann–Whitney U test. Statistical significance was defined as a two-sided p < 0.05. HBsAg seroprevalence was 4.8% (29/600; 95% CI, 3.4–6.9%), and anti-HCV seroprevalence was 4.5% (27/600; 95% CI, 3.1–6.5%). B-positive was the most frequent blood group (33.0%). Neither HBsAg nor anti-HCV reactivity was significantly associated with ABO/Rh blood group (χ² = 10.17, p = 0.179 and χ² = 4.16, p = 0.762, respectively). Age distributions did not differ significantly between reactive and nonreactive donors for either marker (p = 0.210 and p = 0.922, respectively). No significant association was observed between HBsAg and anti-HCV reactivity (p = 0.858). Approximately one in twenty donors screened reactive for each marker, underscoring the importance of reliable donor screening, appropriate confirmatory testing, donor counselling and referral. These findings represent screening-marker seroprevalence rather than confirmed active infection and should be interpreted within the limitations of rapid testing and the sampled male donor population.

Read PDF

Similar papers

Open access Oct 2026

The hidden burden of viral hepatitis B and C in healthcare settings: a cross-sectional study of seroprevalence, predictors, and occult infection

Background Bloodborne viral hepatitis B and C remain critical occupational hazards for healthcare workers (HCWs). Current mandatory screening in some countries, including Russia, relies solely on hepatitis B surface antigen (HBsAg) detection, which may overlook occult infections. This study aimed to evaluate the preval...

M. Kostinov, O. Isaeva, I. Samolygo et al. · 0 citations
Open access Nov 2026

Prevalence of Reactive Screening Markers for HIV, Hepatitis B, Hepatitis C, and Syphilis Among Blood Donors at the Provincial Hospital of Sarh, Chad: A Retrospective Cross-Sectional Study

HBV and syphilis were the most frequent reactive screening markers among blood donors at Sarh Provincial Hospital, Chad, and strengthening voluntary non-remunerated donation, quality assurance, confirmatory testing, and surveillance may improve blood safety.

A. Mahamat, Mahamat Hassan Abdel-aziz, Abdoulaye Brahim Bechir et al. · 0 citations
Open access Sep 2026

Seroprevalence of Hepatitis B Surface Antigen and Viral Load Profile Among Patients Attending A Tertiary Care Hospital in Delhi NCR Region: A Cross-Sectional Study

The majority of HBsAg-positive patients harbour substantial viral loads with concurrent hepatocellular injury, underscoring the need for early screening, viral load monitoring, and timely clinical intervention.

G. Pandey, A. Rawat, R. Agarwal · 0 citations
Open access Oct 2026

Trend Analysis of Hepatitis C Seroreactivity in Voluntary Blood Donors at a Stand-Alone Blood Centre: A Retrospective Study

It is demonstrated that HCV seroreactivity among voluntary blood donors remained consistently low over the six-year study period, reflecting the effectiveness of existing blood safety measures and the need to monitor local donor demographics.

Palak Panchal, Archana Pandey, Jhalak Patel et al. · 0 citations
Open access 2026

Seroprevalence and demographic determinants of hepatitis B and C among outpatients in Babylon, Iraq

Blood-borne viral hepatitis remains a major public-health burden, and population-level screening is essential to map its distribution and risk. This study assessed the seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection among outpatients in Al-Musayyib city, Babylon Governorate, Iraq, and ex...

I. Yaseen · 0 citations
Open access Oct 2026

Prevalence and factors associated with hepatitis B surface antibody seroprotection among healthcare workers undergoing laboratory testing at Eastgate Clinic, Windhoek, Namibia: A retrospective cross-sectional study

Healthcare workers are occupationally exposed to blood and body fluids and require effective protection against hepatitis B virus infection. Evidence on hepatitis B surface antibody (anti-HBs) seroprotection among healthcare workers in Namibia remains limited. We estimated the prevalence of anti-HBs seroprotection and...

T. Mafumhe, V. Charamba, H. Mugauri et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.